Morphine (MOR) Saliva Rapid Test

Morphine is an opioid medicine prescribed for severe pain when other pain medicines are not effective or cannot be used. In professional drug testing, morphine is included in opioid or opiate screening because it may appear due to prescribed medical use, misuse, or exposure to opioid-related substances. Since morphine can cause drowsiness, slowed breathing, dependence, and overdose risk, professional monitoring is important in clinical, workplace, forensic, and rehabilitation settings.

• Saliva drug testing is widely used because it is non-invasive, easy to collect, and suitable for observed collection.
• Oral-fluid testing is useful when urine collection is difficult or when a quick, observed specimen collection method is preferred.
• The Morphine MOR Saliva Rapid Test helps screen oral-fluid samples for morphine presence in a fast and practical way.

The Morphine (MOR) Saliva Rapid Test by LARKSOIS Pharma may be used in professional diagnostic and institutional screening environments.

Applications

• Drug of abuse screening programs
• Workplace and pre-employment screening support
• Rehabilitation and de-addiction monitoring
• Clinical toxicology screening
• Roadside or recent-use screening environments
• Forensic and compliance screening
• International diagnostic supply programs
• Laboratory and professional screening workflows

• The Morphine MOR Saliva Rapid Test generally works through a rapid immunoassay format. A saliva sample is collected using the provided oral-fluid collection method, and the sample is then applied to or processed through the test device according to the product insert.
• The test gives a visual qualitative result based on the 20 ng/mL cut-off. A non-negative result means morphine may be present at or above the test threshold.
• A negative result means morphine was not detected above the stated cut-off at the time of testing. For legal, employment, clinical, or official decisions, non-negative rapid results should be confirmed using a validated laboratory method.

The Morphine (MOR) Saliva Rapid Test uses a rapid oral-fluid screening method for qualitative detection of morphine. It is designed to provide a preliminary screening result at the stated 20 ng/mL cut-off.

Benefits

• Fast oral-fluid screening for morphine
• 20 ng/mL cut-off for professional screening requirements
• Non-invasive saliva specimen collection
• Suitable for observed collection settings
• Useful for drug of abuse screening programs
• Supports workplace, clinical, rehabilitation, and forensic testing
• Easy-to-read rapid test format
• Designed for international diagnostic supply markets

The Morphine (MOR) Saliva Rapid Test is designed for saliva or oral-fluid specimens. Saliva testing is practical, non-invasive, and useful for professional screening programs where observed collection and rapid results are important.

Guidance

• Use saliva or oral-fluid specimens only
• Collect saliva using the correct oral-fluid procedure
• Avoid specimen contamination
• Follow the package insert carefully
• Read results only within the stated time window
• Do not reuse the test device
• Confirm important or disputed results through laboratory testing

Note

A rapid screening result should be considered preliminary unless confirmed by a validated laboratory method where required.

The Morphine (MOR) Saliva Rapid Test by LARKSOIS Pharma has a stated cut-off of 20 ng/mL. This means the test is designed to screen oral-fluid specimens for morphine at or above the validated threshold. LARKSOIS Pharma should mention the exact performance details according to the final product insert, technical file, and regulatory documentation.

Instructions

• Fast oral-fluid screening for morphine
• 20 ng/mL cut-off for professional screening requirements
• Non-invasive saliva specimen collection
• Suitable for observed collection settings
• Useful for drug of abuse screening programs
• Supports workplace, clinical, rehabilitation, and forensic testing
• Easy-to-read rapid test format
• Designed for international diagnostic supply markets

Note

The Morphine MOR Saliva Rapid Test by LARKSOIS Pharma provides a practical screening option for professional users who need speed, convenience, and reliable preliminary testing.

Steps

• Bring the test device and saliva collection materials to the recommended testing condition
• Open the sealed pouch only when ready to test
• Collect saliva according to the approved oral-fluid collection method
• Apply or process the saliva specimen according to the test instructions
• Wait for the test reaction to complete within the instructed time
• Read the result within the approved interpretation window
• Dispose of used materials according to laboratory safety rules

Note

The exact procedure must follow the official LARKSOIS Pharma product insert supplied with the Morphine (MOR) Saliva Rapid Test.

Positive

A positive or non-negative result suggests that morphine may be present in the saliva specimen at or above the stated cut-off. Positive results are preliminary and should be confirmed using a recognized laboratory method where required.

Negative

A negative result suggests that morphine was not detected or was below the cut-off at the time of testing. A negative result does not always rule out exposure if sample quality, collection timing, or the detection window affects the result.

Invalid

If the valid control indicator does not appear, the test is invalid. The test should be repeated with a new device and properly collected saliva specimen according to the product insert.

Instructions

• Store according to the product label and package insert
• Keep the test device sealed until use
• Protect from moisture and direct sunlight
• Avoid using expired or damaged kits
• Use only approved oral-fluid collection materials
• Read results only within the stated time window
• Do not reuse the test device

Instructions

• For professional screening use only
• Use saliva or oral-fluid specimen only as directed
• Do not reuse the test device
• Follow the product insert carefully
• Avoid specimen contamination
• Handle all specimens with standard safety precautions
• Do not interpret results after the recommended reading time
• Confirm presumptive positive results with laboratory testing
• Follow applicable drug testing laws and reporting requirements

LARKSOIS Pharma provides international-quality pharmaceutical and diagnostic products for healthcare, screening, and global supply markets. The Morphine MOR Saliva Rapid Test is developed for professional use by distributors, laboratories, hospitals, rehabilitation centers, workplace testing companies, and toxicology screening programs.

Advantages

• International diagnostic product focus
• Reliable rapid testing solutions
• Suitable for laboratories and healthcare suppliers
• Distributor-friendly product format
• Supports drug of abuse screening programs
• Designed for practical oral-fluid screening workflows
• Quality-focused standards under LARKSOIS Pharma